Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in throat, kidney and colorectal cancer. Here is what they found about living well during and after treatment.
|Articles|February 24, 2020
Do You Have a Daily Self-Care Routine?
Author(s)CURE staff
We asked our readers on social media if they have a daily self-care routine. Here’s what they had to say.
Advertisement
Self-care is important for anyone, but especially for patients with cancer and survivors as they recoup after rough rounds of treatment with both mental and physical side effects to manage. So, we asked our HEAL® readership on social media what they do for self-care and how it helps them. Here’s what they had to say:
“Aerobic dancing twice a week walks on my country road and watercolors.” — Jane
“Gratitude Journal.” — @jbmarcy5
“Walking the dogs and reading.” — Barbara
“Positive conversation with self before my feet hit the ground!” — Jodi
“Standing yoga routine.” — Leslie
“Daily walk, plus meditation and self-reiki.” — @dreamtime_wellness
“Believing and acting like everything is normal and not dwelling on my myeloma.” — James
Advertisement
Related to this article
New research found that nearly 1 in 5 second-level appeals for denied cancer medications under Medicare Part D were successful, raising questions about how insurers make coverage decisions and what patients can do when their treatment is denied.
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
A national survey study of about 200,000 adults, published in Supportive Care in Cancer, found that people caring for someone with cancer had 89% higher odds of frequent mental distress than people who were not caregivers.
Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, kidney cancer, colorectal cancer and stomach and esophageal cancer kept helping patients years later.
Dr. Jacqueline Barrientos shares how a targeted therapy, a determined care team and a stranger’s generosity gave a 72-year-old man with hairy cell leukemia and kidney failure a second chance.
A clinical trial will test zanubrutinib plus sonrotoclax as a fixed-duration, chemotherapy-free treatment for hairy cell leukemia, aiming for undetectable disease.
Advertisement
Advertisement
Trending on CURE
1
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
2
Top 5 Takeaways From ESMO 2026 That Patients Should Know
3
Neuro-Oncologist Answers Common Questions About Brain Cancer Diagnosis and Treatment
4
4 Lung Cancer Results From ESMO 2026 Patients Should Know
5